Adaptation of a Chinese ferret badger strain of rabies virus to high-titered growth in BHK-21 cells for canine vaccine development

Archives of Virology

Volumn 157, Issue 12, 2012, Pages 2397-2403

  Liu, Ye ^a   Zhang, Shoufeng ^a   Zhang, Fei ^a   Hu, Rongliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

cell culture adapted virus; Chinese ferret badger; rabies virus; vaccine

Indexed keywords

LIVE VACCINE; RABIES VACCINE; VIRUS RNA;

ADAPTATION; ANIMAL; ANIMAL DISEASE; ARTICLE; BRAIN; CELL LINE; CHINA; CLASSIFICATION; DOG; DOG DISEASE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAMSTER; IMMUNOLOGY; MOUSE; MUSTELIDAE; NUCLEOTIDE SEQUENCE; RABIES; RABIES VIRUS; RANDOMIZATION; SPECIES DIFFERENCE; VIROLOGY; VIRUS CULTURE; VIRUS GENOME;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BASE SEQUENCE; BRAIN; CELL LINE; CHINA; CRICETINAE; DOG DISEASES; DOGS; GENOME, VIRAL; MICE; MUSTELIDAE; RABIES; RABIES VACCINES; RABIES VIRUS; RANDOM ALLOCATION; RNA, VIRAL; SERIAL PASSAGE; SPECIES SPECIFICITY; VACCINES, ATTENUATED;

CANIS FAMILIARIS; MELOGALE MOSCHATA; MUS; MUSTELA; RABIES VIRUS;

EID: 84870294146     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1436-2     Document Type: Article

References (25)

1. Zhang YZ, Xiong CL, Zou Y, Wang DM, Jiang RJ, Xiao QY, Hao ZY, Zhang LZ, Yu YX, Fu ZF (2006) Molecular characterization of rabies virus isolates in China during 2004. Virus Res 121(2): 179-188.
2. Hu RL, Tang Q, Tang JR, Fooks AR (2009) Rabies in China: an update. Vector Borne Zoonotic Dis 9(1): 1-12.
3. Lodmell DL, Smith JS, Esposito JJ, Larry CE (1995) Cross-protection of mice against a global spectrum of rabies virus variants. J Virol 69(8): 4957-4962.
4. Hu RL, Fooks AR, Zhang SF, Liu Y, Zhang F (2008) Inferior rabies vaccine quality and low immunization coverage in dogs (Canis familiaris) in China. Epidemiol Infect 136(11): 1556-1563.
5. Wu XF, Hu RL, Zhang YZ, Dong GM, Rupprecht CE (2009) Reemerging rabies and lack of systemic surveillance in People's Republic of China. Emerg Infect Dis 15(8): 1159-1164.
6. Liu Y, Zhang SF, Wu XF, Zhao JH, Hou YL, Zhang F, Velasco-Villa A, Rupprecht CE, Hu RL (2010) Ferret badger rabies origin and its revisited importance as potential source of rabies transmission in Southeast China. BMC Infect Dis 10: 234-241.
7. Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs. WHO Technical Report Series No 941, 2007, 104-106.
8. Cliquet F, Aubert M, Sagne L (1998) Development of a fluorescent antibody virus neutralization test (FAVN test) for the quantitation of rabies-neutralizing antibody. J Immunol Methods 212(1): 79-87.
9. Dean DJ, Abelseth MK (1996) The fluorescent antibody test. In: Meslin F-X, Kaplan MM, Koprowski H (eds) Laboratory Techniques in Rabies, 4th edn. World Health Organization, Geneva, pp 88-93.
10. Koprowski H, Cox HR (1948) Studies on chick-embryo-adapted rabies virus; culture characteristics and pathogenicity. J Immunol 60: 533-544.
11. Abdel-Alim GA, Saif YM (2001) Pathogenicity of cell culture-derived and bursa-derived infectious bursal disease viruses in specific-pathogen-free chickens. Avian Dis 45(4): 844-852.
12. Goto A, Hayasaka D, Yoshii K, Mizutani T, Kariwa H, Takashima I (2003) A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness. Vaccine 21(25-26): 4043-4051.
13. Faber M, Faber ML, Papaneri A, Bette M, Weihe E, Dietzschold B, Schnell MJ (2005) A single amino acid change in rabies virus glycoprotein increase virus spread and enhance virus pathogenicity. J Virol 79(22): 14141-14148.
14. Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, Schnell MJ, Dietzschold B (2004) Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc Natl Acad Sci USA 101: 16328-16332.
15. Ito H, Minamoto N, Watanabe T, Goto H, Rong LT, Sugiyama M, Kinjo T, Mannen K, Mifune K, Konobe T, Yoshida I, Takamizawa A (1994) A unique mutation of glycoprotein gene of the attenuated RC-HL strain of rabies virus, a seed virus used for production of animal vaccine in Japan. Microbiol Immunol 38: 479-482.
16. Faber M, Li J, Kean RB, Hooper DC, Aluqupalli KR, Dietzschold B (2009) Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc Natl Acad Sci USA 106(27): 11300-11305.
17. Faber M, Faber ML, Papaneri A, Bette M, Weihe E, Dietzschold B, Schnell MJ (2005) A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J Virol 79(22): 14141-14148.
18. Takayama-Ito M, Ito N, Yamada K, Sugiyama M, Minamoto N (2006) Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice. Virus Res 115(2): 169-175.
19. Yamada K, Park CH, Noguchi K, Kojima D, Kubo T, Komiya N, Matsumoto T, Mitui MT, Ahmed K, Morimoto K, Inoue S, Nishizono A (2012) Serial passage of a street rabies virus in mouse neuroblastoma cells resulted in attenuation: potential role of the additional N-glycosylation of a viral glycoprotein in the reduced pathogenicity of street rabies virus. Virus Res 165(1): 34-45.
20. Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H (1983) Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 80(1): 70-74.
21. Wunner WH, Dietzschold B, Smith CL, Lafon M, Golub E (1985) Antigenic variants of CVS rabies virus with altered glycosylation sites. Virology 140(1): 1-12.
22. Benmansour A, Leblois H, Coulon P, Tuffereau C, Gaudin Y, Flamand A, Lafay F (1991) Antigenicity of rabies virus glycoprotein. J Virol 65(8): 4198-4203.
23. Luo TR, Minamoto N, Hishida M, Yamamoto K, Fujise T, Hiraga S, Ito N, Sugiyama M, Kinjo T (1998) Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies. Microbiol Immunol 42(3): 187-193.
24. Houimel M, Dellagi K (2009) Peptide mimotopes of rabies virus glycoprotein with immunogenic activity. Vaccine 27(34): 4648-4655.
25. Lafon M, Ideler J, Wunner WH (1984) Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Dev Biol Stand 57: 219-225.